Followers | 14 |
Posts | 1572 |
Boards Moderated | 0 |
Alias Born | 06/14/2018 |
Wednesday, September 12, 2018 6:42:18 PM
the difference between "stop loss" and "stop limit"
It gets a bit complicated, and I have used "stop limit", BUT I would only use that in very specific situations that usually revolve around upcoming news.
OK, same example I've been using.
You bought a $5, it goes up to $15, and you want to protect A PORTION of your profit.
With a stop loss, you would do something like put in that stop loss at $3. And that is the end of it and you know how that works. If it goes down $3, you will sell. If it opens that morning down $5, you will sell. If it opens that morning down $14, you will STILL sell (but this rarely happens for no reason).
With a stop "limit" you elect to put a bottom "limit" at what you are willing to sell at, AND ANYTHING BELOW your limit, you will NOT sell.
I will give you an example of a few ways that will work (trading during the day and trading at market open), and then I will tell you how I use stop limits and why.
Same example, buy at $5, it goes to $15, you put in a "stop limit" for $3 with a "limit" at $5.
OK, now let's say it's a very small, very thinly traded stock and your order is to sell 5000 shares.
It goes down $3 and you sell 1000 shares, it goes down $4.10 and you sell another 1000 shares …… it goes down $5.20 and you WILL NOT sell your remaining 3000 shares because being down $5.20 the price is now BELOW your bottom limit. That can be very bad because if it continues down another $5 you will not sell your shares and will be stuck taking the loss. That stock could end the day at 44 cents and you will still own any remaining shares.
Another example (using different numbers to make the point), you buy at $5, it went up to $200, and you want tp protect a portion of your giant profit.
You stop "limit" at $10 with a "limit" at $20.
OK, bad news happens over night and it opens down $20.10 …. you will NOT SELL because it is below your bottom limit.
SOOOOOOOOOO, if it keeps going down all day, it could end the day DOWN $190 and you still own because you never got to sell because you put in a bottom limit.
So, in general, I don't use stop limits because of the above, if I want to protect profit, I want to protect profit, period.
Now, how and why do I use them.
I own a biotech stock, and I know that phase 2 news will be released in 2 days. I also know/suspect that the news will NOT be great, but it will also NOT be horrible.
And I am going to stop here and say ….. this is why I talk about greed and fear, and the OVEREACTION that ALWAYS happens on both sides.
Think of it like a rubber band being stretched one way or the other.
One way is greed, the other way is fear. People almost ALWAYS stretch it TOO MUCH. And what happens when you stretch a rubber band way out? It bounces back. Believe it or not, that directly relates to stock prices. The down stretch could be fear as fear, it could be fear as profit taking, it could be fear because famous Joe Blow sold.
OK, back to the example.
I bought at $5 and it went up to $200.
News coming out in 2 days, not Great, but not horrible.
NOW, the news could be released before the open, or after the close, or the stock could be halted pending the news (as happens a lot)
What else do I KNOW.
I KNOW people will OVERREACT way too much.
I know that as soon as the news comes out and as soon as the stock opens, the stock price will open at $110 because of fear - panic - rubber band stretch.
It may even continue down to $95 per share for the same reasons.
But what ALWAYS happens (most of the time), a couple of things, some people catch their breath, realize it's not the end of the world or the stock and buy. Other people, greed will kick in and they will buy cheap.
At the end of the day (or a few days), stock is at $175 and the world is fine.
NOW, if I put in a stop "LOSS" at $10, I would have been forced to sell at the open at $110 (losing $90 a share) (which I don't want to do because I still believe in the stock).
BUT with a stop limit at $10 and a limit at $20, I will be protected and NOT FORCED to sell at $110, down $90.
In general, use staggered, trailing stop losses to protect a "PORTION" of your profits. ….. and forget the "limit" trade.
Recent MRKR News
- Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors • GlobeNewswire Inc. • 08/28/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 08:47:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:39:13 PM
- Marker Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 08/14/2024 08:30:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 11:12:59 AM
- Marker Therapeutics Awarded $2 Million Grant from NIH in Support of Phase 1 Study Investigating MT-601 in CAR-Relapsed Patients with Non-Hodgkin’s Lymphoma • GlobeNewswire Inc. • 08/12/2024 11:00:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 08:05:47 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 05/17/2024 10:25:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:40:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:03:21 PM
- Principal Investigator from City of Hope National Medical Center Invited to Present Clinical Data from Marker Therapeutics APOLLO Study at 11th Global Summit on Hematologic Malignancies • GlobeNewswire Inc. • 04/08/2024 11:00:39 AM
- Marker Therapeutics Reports Year-End 2023 Corporate and Financial Results • GlobeNewswire Inc. • 03/25/2024 09:45:00 PM
- Marker Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference • GlobeNewswire Inc. • 03/22/2024 04:30:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 01:02:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 12:58:51 PM
- Marker Therapeutics Receives Approval from United States Adopted Name (USAN) Council and International Nonproprietary Names (INN) Expert Committee for “Neldaleucel” as Nonproprietary Name for MT-601 • GlobeNewswire Inc. • 01/22/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:30:48 PM
- Marker Therapeutics Announces Clinical Program Updates and Pipeline Prioritization • GlobeNewswire Inc. • 01/08/2024 01:24:49 PM
- Marker Therapeutics Announces Participation in Biotech Showcase and the 19th Annual Non-Dilutive Funding Summit During “J.P. Morgan Week 2024” • GlobeNewswire Inc. • 12/21/2023 04:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 12:35:22 PM
- Marker Therapeutics Announces Sustained Complete Response in First Lymphoma Patient Treated with MT-601 following CAR T Relapse • GlobeNewswire Inc. • 12/11/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 09:37:41 PM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM